Overall, our study demonstrated the unique role of SPARC in aerobic glycolysis and resistance to 5‐FU chemotherapy in CRC and successfully illustrated the important impact of the SPARC/STAT3/HK2 axis in this process (Figure 7). This evidence concerns the gene HK2 and colorectal carcinoma.